Table 1 Baseline characteristics.

From: Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease

Baseline characteristics

N = 14

Age, years

62 [59–69]

Male

6 (42.9)

Systolic blood pressure, mmHg

129 ± 13

Diastolic blood pressure, mmHg

79 ± 11

BMI, kg/m2

26.3 ± 3.7

Smoking

Active

3 (21.4)

Former

7 (50)

Never

4 (28.6)

Creatinine, µmol/L

141 [106–210]

eGFR, mL/min/1.73 m2

39 ± 12

Plasma phosphate, mmol/L

1.0 ± 0.1

Plasma calcium, mmol/L

2.4 ± 0.1

Plasma urea, mmol/L

10.6 [8.9–12.9]

Total protein in urine (portion), g/L

0.07 [0.04–0.34]

Total cholesterol, mmol/L

6.0 ± 1.6

HDL-cholesterol, mmol/L

1.5 ± 0.4

LDL-cholesterol, mmol/L

3.7 ± 1.1

Triglycerides, mmol/L

1.3 [0.9–1.9]

Leukocytes, *109/L

6.2 ± 2.4

hs-CRP, mg/L

2.3 [0.9–5.5]

Glucose, mmol/L

5.7 ± 0.9